Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report) was up 47.4% on Saturday . The stock traded as high as C$0.14 and last traded at C$0.14. Approximately 1,312,210 shares were traded during mid-day trading, an increase of 427% from the average daily volume of 249,010 shares. The stock had previously closed at C$0.10.
Voyageur Pharmaceuticals Stock Performance
The company has a 50-day moving average of C$0.08 and a 200 day moving average of C$0.06. The company has a quick ratio of 0.84, a current ratio of 0.17 and a debt-to-equity ratio of 3.21. The firm has a market capitalization of C$19.53 million, a PE ratio of -14.00 and a beta of 0.32.
Voyageur Pharmaceuticals Company Profile
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.
See Also
- Five stocks we like better than Voyageur Pharmaceuticals
- How to Use High Beta Stocks to Maximize Your Investing Profits
- ServiceTitan Made Waves in Its IPO, But Is the Stock a Buy?
- The Basics of Support and Resistance
- Netflix: Is This the Perfect Time to Buy a Streaming Powerhouse?
- Trading Halts Explained
- Goldman Sachs Unveils 3 Massive Opportunities for 2025 Investors
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
